Immunotherapy Resistance Committee

The Immunotherapy Resistance Committee is convening stakeholders from across the field of immunotherapy to help develop unified definitions of immunotherapy resistance in order to support future drug development. The committee will conduct in-person meetings and teleconferences to develop various outputs. The committee represents the society when requested and develops talking points for the Board of Directors when asked.

Chair

Ryan J. Sullivan, MD – Massachusetts General Hospital